Ashland Global Holdings Inc. offers specialized chemical solutions globally. The company is headquartered in Covington, Kentucky.
138 articles
Ashland Global Holdings Inc will host a virtual Innovation Day on September 17, 2026, presenting technology platforms and commercial progress aimed at driving organic growth.
Ashland has commercially launched permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drug products. The excipient supports oral alternatives to injectable therapie
Ashland Inc. launched Permexa sodium caprate, an intestinal permeation enhancer for oral peptide and biologic drugs such as GLP-1 agonists. This excipient aims to improve formulation consistency and s
Ashland has launched permexa™ sodium caprate, an intestinal permeation enhancer designed to facilitate the oral delivery of peptides and biologics such as GLP-1 agonists. This excipient aims to improv
Ashland Inc. received a Moderate Buy consensus from twelve brokerages with a $73.90 average price target, supported by high institutional ownership and a quarterly dividend.
Massachusetts Financial Services filed an amended Schedule 13G disclosing a 4.5% beneficial ownership stake in Ashland Inc., holding over 2 million shares as of June 30, 2026.
Omega Advisors increased its stake in specialty materials firm Ashland Inc by 1.215 million shares, though analyst models suggest the stock remains 9% overvalued despite strong financial health scores
Ashland Inc. has announced updates to its Board of Directors' committee assignments for new directors Allen A. Spizzo and Peter T. Thomas, effective August 7, 2026.
An analyst suggests Ashland Global Holdings Inc., a chemicals maker, could be valued at $90 per share in a potential takeover. The company is considering a sale following received takeover interest.
Ashland Global Holdings Inc. announced a quarterly dividend and established a Capital Allocation Advisory Committee following an agreement with Ancora Holdings Group. These changes aim to influence in
Ashland Global Holdings Inc declared a quarterly cash dividend of $0.42 per share, payable on September 15, 2026, to shareholders of record as of September 1, 2026.
Ashland Global Holdings Inc declared a quarterly cash dividend of $0.42 per share, payable on September 15, 2026. Stockholders of record as of September 1, 2026, will receive the payment.
Ashland Inc. shares rose 6% after reports emerged that the chemical maker is exploring a potential sale. The company has engaged Citigroup and Lazard to solicit offers from strategic and private equit
Analysts raised Ashland Inc.'s average 12-month price target to $79.91, implying 11% upside, with a consensus Buy rating from 12 analysts.
Ashland Inc. director Allen A. Spizzo filed an initial Form 3 to register insider status, with no equity transactions reported in the filing.
Ashland Global Holdings Inc. (MUN:AHT) displays its forward price-to-earnings ratio on the Munich Stock Exchange, where the market is currently closed with no trades recorded. Data is provided via Tra
Omega Capital Partners reported a 6.4% beneficial ownership stake in Ashland Inc., totaling 2.9 million shares via a Schedule 13G filing indicating a passive investment position.
A law firm is investigating Ashland Inc. after Q2 2026 results missed estimates due to operational challenges at its Hopewell manufacturing facility, causing a stock price drop.
Bronstein, Gewirtz & Grossman, LLC is investigating Ashland Inc. after Q2 2026 financial results missed estimates and operational challenges at its Hopewell facility impacted guidance.
Ashland Global Holdings reported Q3 2026 adjusted EPS of $1.02 with $103 million in free cash flow, despite a mild stock pullback. Market analysts assess if this cash generation addresses lingering ma
Ashland Global Holdings extended its $70 million receivables securitization facility with PNC Bank until July 2028 to maintain liquidity through a bankruptcy-remote special purpose entity.
Ashland Inc. reported Q3 2026 earnings with an EPS of $1.02 and revenue of $497 million, exceeding analyst estimates despite a 7.34% year-over-year revenue decline.
TradingView displays the enterprise value to forward revenue metric for Ashland Inc. (SWB:AHT), though the page currently lacks specific financial data or analysis.
Vanguard Portfolio Management LLC disclosed a 5.42% stake in Ashland Inc via Schedule 13G, holding 2.48 million shares as of June 30, 2026.
Ashland Inc.'s SVP and CTO Osama M. Musa exercised 9,793 Stock Appreciation Rights under a Rule 10b5-1 plan, acquiring 1,267 common shares at $57.96 per share.
Ashland Inc reported 7% year-over-year sales growth in Q3 2026, driven by volume increases in Life Sciences and Personal Care. However, profitability declined due to production challenges and cost pre
Ashland Inc. reported Q3 2026 revenue of $497 million, up 7.3% year-over-year, driven by Life Sciences and Personal Care segments. The company also noted progress in its manufacturing network optimiza
Ashland Global Holdings Inc. Senior Vice President Alessandra Faccin converted 3,215 RSUs to common stock on July 27, 2026, withholding shares for taxes. Her direct equity award balance totaled 9,646
Ashland Global Holdings reported strong Q3 2026 results, beating expectations with $1.02 EPS and $497 million revenue. Growth was driven by robust demand in its Life Sciences segment, specifically pha
Ashland Global Holdings reported Q3 fiscal 2026 adjusted earnings of $1.02 per share, missing estimates, while sales rose 7% to $497 million driven by volume growth. The company maintained sales guida
ChemBrief